Vitiligo in a patient undergoing nivolumab treatment for non–small cell lung cancer

Cory Kosche, Nisha Mohindra, Jennifer N. Choi*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

21 Scopus citations
Original languageEnglish (US)
Pages (from-to)1042-1044
Number of pages3
JournalJAAD Case Reports
Issue number10
StatePublished - Nov 2018


  • PD-1 inhibitor
  • adverse event
  • checkpoint inhibitor
  • immunotherapy
  • nivolumab
  • non–small cell lung cancer
  • vitiligo

ASJC Scopus subject areas

  • Dermatology

Cite this